n-3 PUFAs Reduce Mortality and Hospital Admissions in Patients With Symptomatic Hea... (eline committees toadd this treatment to...)

n-3 PUFAs Reduce Mortality and Hospital Admissions in Patients With Symptomatic Heart Failure

Date:9/2/2008

eline committees to add this treatment to the established therapies of congestive heart failure."

References

1. GISSI-HF investigators. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial Lancet 2008; Published online August 31st 2008.

2. Marchioli R, Marfisi RM, Borrelli G, Chieffo C, Franzosi MG, Levantesi G, et al. Efficacy of n-3 polyunsaturated fatty acids according to clinical characteristics of patients with recent myocardial infarction: insights from the GISSI-Prevenzione trial. Journal of Cardiovascular Medicine (Hagerstown, MD) 2007 Sep;8 Suppl 1:S34-7.

3. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 1999 Aug 7;354(9177):447-55.

Notes for Editors

About GISSI and the GISSI-HF Trial

The Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI), is considered as one of the most important research teams in the cardiovascular field. The GISSI has produced a series of large-scale clinical trials (GISSI 1 (http://www.gissi.org/Egissi1/T_Intro.php), GISSI 2 (http://www.gissi.org/Egissi2/T_Intro.php), GISSI 3 (http://www.gissi.org/Egissi3/T_Intro.php), GISSI Prevention (http://www.gissi.org/Egissip/T_Intro.php)), which have involved more than 60.000 patients with myocardial infarction (AMI).

The rationale for the GISSI-HF* trial was based on positive results with n-3 PUFAs in a subgroup of patients from a previous GISSI- Prevenzione Tri
'/>"/>

SOURCE Solvay Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6
Related medicine technology :

1. Prasugrel Head-to-Head Study Showed Reduced Cardiovascular Events in Diabetes Patients by 30 Percent Compared with Clopidogrel
2. National Study Shows Magnesium Sulfate Reduces Risk of Cerebral Palsy in Premature Births
3. Bad News to Bad Bugs: Northern Antibiotics Develops Novel Polymyxins With Reduced Toxicity
4. DaVita Strives to Improve Quality of Life and Reduce Overall Costs of Kidney Care Through Community-Based Education
5. New Study: Pine Bark Significantly Reduces Menstrual Pain
6. ACTEMRA(R) (tocilizumab) Significantly Reduces Rheumatoid Arthritis Signs and Symptoms Regardless of Previous Therapy in Two New Global Studies
7. Patients Taking Cymbalta(R) Reported Reduced Pain Severity of Osteoarthritis of the Knee in New Study
8. Video: Clinical Study Shows Liraglutide Reduced Blood Sugar, Weight, and Blood Pressure in Patients with Type 2 Diabetes
9. The Largest Ever Study of Diabetes Shows Intensive Glucose Control Reduces Serious Complications
10. CellCept(R) and a Reduced Level of CNI Shows Trend Towards Preservation of Kidney Function Versus a Standard-Dose CNI
11. Data Show Rufinamide, an Investigational Adjunctive Treatment for Lennox- Gastaut Syndrome, Reduced Drop Attacks by More Than 40%

Post Your Comments:

(Date:11/20/2009)...irstCall/ -- Medco Health Solutions, Inc (NYSE: ... American healthcare through an advanced, wired ph...quality clinical care and fundamentally bending th...or the benefit of patients and payors alike. ,,...ts strategy enable "Smarter Medicine" to help addr...

(Date:11/20/2009)...re/ -- Reportlinker.com announces that a new marke..., Pipettes & Pipettors - A Global Market P...164373/Pipettes--Pipettors---A-Global-Market-Persp...r&utm_campaign=prnewswire ,, Pipettes and...research laboratory. Large-scale applications in l...

(Date:11/20/2009)...re/ -- Reportlinker.com announces that a new marke..., Medical Adhesives and Sealants - A US Market...242/Medical-Adhesives-and-Sealants---A-US-Market-R...&utm_campaign=prnewswire ,, The use of me...e in medical devices and equipments. Cutting edge ...

Breaking Medicine Technology:Medco Reforming Healthcare with 'Smarter Medicine'; Wired, Transformational Pharmacy Model Advances Clinical Quality and Lowers Cost 2 Medco Reforming Healthcare with 'Smarter Medicine'; Wired, Transformational Pharmacy Model Advances Clinical Quality and Lowers Cost 3 Medco Reforming Healthcare with 'Smarter Medicine'; Wired, Transformational Pharmacy Model Advances Clinical Quality and Lowers Cost 4 Medco Reforming Healthcare with 'Smarter Medicine'; Wired, Transformational Pharmacy Model Advances Clinical Quality and Lowers Cost 5 Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 2 Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 3 Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 4 Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 5 Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 6 Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 7 Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 8 Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 9 Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 10 Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 11 Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 12 Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 2 Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 3 Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 4 Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 5 Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 6 Insurance and HMO Industries Spend Nearly 24700 000 Per Day to Kill Health Care Reform Measures 57243 1 Insurance and HMO Industries Spend Nearly 24700 000 Per Day to Kill Health Care Reform Measures 57243 2 Sigma Aldrich to Present at the UBS Global Life Sciences Conference on Monday September 21 2009 14064 1 Pelosi Remarks at Democratic Steering and Policy Committee Forum on Health Insurance Reform 57234 1 Pelosi Remarks at Democratic Steering and Policy Committee Forum on Health Insurance Reform 57234 2 Pelosi Remarks at Democratic Steering and Policy Committee Forum on Health Insurance Reform 57234 3

[0] Medco Reforming Healthcare with 'Smarter Medicine'; Wired, Transformational Pharmacy Model Advances Clinical Quality and Lowers Cost [0] Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective [0] Reportlinker Adds Medical Adhesives and Sealants - A US Market Review

...07 - Clinical results from a,Phase II study presen...ciety (AHS) annual meeting showed that MK-0974, an...ide (CGRP),receptor antagonist, significantly impr...ompared to placebo, and the relief was,sustained t...ted in,the study. Responses specific to other meas...

... weeks achieved an SVR rate at,least comparable to...e favorable quality-of-life scores -, ROCKVILLE, M...Genome Sciences, Inc. today announced the top-line...uferon(R) (albinterferon alfa-2b),in combination w...otype 1 chronic hepatitis C. The Company expects t...

Other Medicine Technology:Merck's Investigational Migraine Treatment MK-0974 Significantly,Improved Migraine Pain on Several Efficacy Measures in a Phase II,Study 2 Merck's Investigational Migraine Treatment MK-0974 Significantly,Improved Migraine Pain on Several Efficacy Measures in a Phase II,Study 3 Merck's Investigational Migraine Treatment MK-0974 Significantly,Improved Migraine Pain on Several Efficacy Measures in a Phase II,Study 4 Merck's Investigational Migraine Treatment MK-0974 Significantly,Improved Migraine Pain on Several Efficacy Measures in a Phase II,Study 5 Human Genome Sciences Announces Positive Final Results Of Phase 2b,Trial of Albuferon 2 Human Genome Sciences Announces Positive Final Results Of Phase 2b,Trial of Albuferon 3 Human Genome Sciences Announces Positive Final Results Of Phase 2b,Trial of Albuferon 4 Human Genome Sciences Announces Positive Final Results Of Phase 2b,Trial of Albuferon 5 Human Genome Sciences Announces Positive Final Results Of Phase 2b,Trial of Albuferon 6 Human Genome Sciences Announces Positive Final Results Of Phase 2b,Trial of Albuferon 7 Human Genome Sciences Announces Positive Final Results Of Phase 2b,Trial of Albuferon 8

Merck's Investigational Migraine Treatment MK-0974 Significantly,Improved Migraine Pain on Several Efficacy Measures in a Phase II,Study Human Genome Sciences Announces Positive Final Results Of Phase 2b,Trial of Albuferon

(Date:11/20/2009)...nderstanding Brain Wiring and Diseases ,, WASHI...my Schmahmann, Professor of Neurology at Harvard M... General Hospital in Boston, on Thursday, November...w field of study called "Connectivity" at the laun...n is an award-winning leader in the field of the c...

(Date:11/20/2009).../ -- Following a recall by Unilever The Stop &...s Country Crock ® Side Dishes DELUXE Cheddar ...e Dishes DELUXE Four Cheese Pasta due to an undecl...ates and UPCs are affected: ,, Shedd,s Country...Rice 21 oz, UPC 027400218316, Best By NOV 29 09 th...

(Date:11/20/2009)...FirstCall/ -- Centene Corporation (NYSE: CNC )...of America Merrill Lynch 2009 Credit Conference, t...Hotel Times Square in New York City. ,, Centene... Eastern Time. Investors and other interested part...presentation at: http://www.veracast.com/webcasts...

(Date:11/20/2009)...-FirstCall/ -- SIRIUS XM Radio (Nasdaq: SIRI ) ...dio Reports: What Every Women Needs to Know About...n journalist Perri Peltz. ,, (Logo: http://ww...,, Doctor Radio Reports: What Every Woman Ne...21 live at 10:00 am ET on Doctor Radio , SIRIUS c...

(Date:11/20/2009)...gency medical service (EMS) providers in the Unite...ts each year. Only 5 to 10 percent of people who ...y cardiopulmonary resuscitation (CPR) provided by ...etter patient outcome. The Resuscitation Outcomes... network to study prehospital treatments for cardi...

Breaking Medicine News(10 mins):Health News:MINDlink Foundation Launches to Connect the Cerebellum to Cures 2 Health News:Stop & Shop Alerts Customers to Voluntary Recall by Unilever 2 Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 2 Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 3 Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 4 Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 5 Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 2 Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 3

[0] MINDlink Foundation Launches to Connect the Cerebellum to Cures [0] Stop & Shop Alerts Customers to Voluntary Recall by Unilever [0] Centene Corporation to Present at Bank of America Merrill Lynch Credit Conference [0] SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms'[0] Effect of real-time CPR feedback reported at resuscitation science symposium

...Pa., March 3 The Quigley,Corporation (Nasdaq: QG...r,the fourth quarter ended December 31, 2007, comp... in 2006. For the year ended December 31, 2007,net...sales,decrease for the Company,s Cold Remedy segme...

...ation to list shares on American Stock Exchange, ...l/ -- China Sky One,Medical, Inc. (OTC Bulletin Bo...cturer, marketer and distributor of pharmaceutical...ng, Jiang Qi,Feng, Zhao Jie and Qian Xu Feng. As a...

...Pa., March 3 The Quigley,Corporation (Nasdaq: QG...completed the sale of it wholly owned subsidiary, ...s health and wellness products through its wholly,... terms of the agreement include a cash purchase pr...

...ed Pain Management Expert Robin Downing, DVM, Will... Aspects Related to Pain and Pets, DENVER, March ...ive webcast for veterinarians on pain management f...e,veterinarian, including common pain issues, over...

...ent and Health & Beauty Get a New Jolt with Java, ...,popular online destination that helps solve peopl...o" instruction on diverse topics, celebrates the,w...oThings.com has created a Caffeine Resource Guide ...

... March 3 The American Cancer Society, (http://www...reness Month aiding,people in preventing the onset... Institute, "153,760 new Colon and Rectal Cancer c...on Cancer or detect,tumors earlier than in the pas...

The Quigley Corporation Reports Fourth Quarter & 2007 Annual Results; Increases Investment to $6.5 million in Pharmaceutical R&D in 2007 China Sky One Medical, Inc. Appoints Four Independent Board Members The Quigley Corporation Announces Sale of Its Health and Wellness Segment Pain Management For Pets, Key Strategies For Veterinarians - Live Webcast to Veterinarians, March 13, 7:00 p.m. to 8:00 p.m. (EDT) Via Morris Animal Foundation HowToDoThings.com Brews Up New Uses for Coffee That Will Perk You Up in Recognition of March's 'Caffeine Awareness Month'SGV Medical Supplies: 'Colostomy Supplies Easier to Obtain for the Colon Cancer Survivor'

Lumenis 950 Slit Lamp

Novus 3000 532 nm Laser System

Selecta Duo Photocoagulator Combination Laser

EnTrust Single Chamber ICD

Medicine Products:

Lumenis 950 Slit Lamp Novus 3000 532 nm Laser System Selecta Duo Photocoagulator Combination Laser EnTrust Single Chamber ICD

n-3 PUFAs Reduce Mortality and Hospital Admissions in Patients With Symptomatic Hea...(eline committees toadd this treatment to...),Health